EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Rescue therapy with upadacitinib in severe Crohn’s disease

Miłosz Caban, Adam Fabisiak, Patrycja Dudek, Ewa Małecka-Wojciesko

Gastroenterology Review · 2026 · 21 (2) · 222-227

DOI: 10.5114/pg.2026.161902 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Gastroenterology Review, 2026. Verfasst von Miłosz Caban und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Tract Diseases, Faculty of Medicine, Medical University of Lodz, Poland. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crohn’s disease (CD) is characterised by chronic, transmural inflammatory response occurring in various segments of the digestive tract. The Crohn’s disease activity index (CDAI) is the primary clinical tool for determining the current disease severity. Despite progress in inflammatory bowel disease (IBD) pharmacotherapy, at least 20% of patients will experience a severe flare requiring hospitalisation. The management of the acute severe Crohn’s-associated colitis represents a significant medical challenge [1, 2]. The initial recommended management is intravenous steroids. Lack of significant clinical improvement within a week is an indication for therapy intensification. Prior to surgery, rescue therapy with biologics may be considered. In such cases, adalimumab and infliximab (IFX) may be effective; however, IFX seems to be the most effective due to weight-based dosing and generally higher doses used than those of adalimumab. In addition, IFX may be more efficient due to intravenous administration and slightly higher

Autor:innen und Institutionen

  • Department of Digestive Tract Diseases, Faculty of Medicine, Medical University of Lodz, Poland.

Zitieren

APA

Caban, M., Fabisiak, A., Dudek, P., & Małecka-Wojciesko, E. (2026). Rescue therapy with upadacitinib in severe Crohn’s disease. Gastroenterology Review, 21(2), 222-227. https://doi.org/10.5114/pg.2026.161902

Vancouver

Caban M, Fabisiak A, Dudek P, Małecka-Wojciesko E. Rescue therapy with upadacitinib in severe Crohn’s disease. Gastroenterology Review. 2026;21(2):222-227. doi:10.5114/pg.2026.161902

BibTeX
@article{Caban2026,
  author = {Caban, Miłosz and Fabisiak, Adam and Dudek, Patrycja and Małecka-Wojciesko, Ewa},
  title = {Rescue therapy with upadacitinib in severe Crohn’s disease},
  journal = {Gastroenterology Review},
  year = {2026},
  volume = {21},
  number = {2},
  pages = {222--227},
  doi = {10.5114/pg.2026.161902}
}
Kostenlos starten →